Performance of Two Silicone Hydrogel Toric Contact Lenses
Sponsored by Johnson & Johnson Vision Care, Inc.
About this trial
Last updated 10 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Ended 17 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Be between 18 and 45 years of age.
- Sign Written Informed Consent (See separate document).
- Be an existing successful daily wear toric soft contact lens.
- Require a visual correction in both eyes (monovision or uniocular fitting is NOT allowed).
- Does not require presbyopic correction (can read J1 @ normal reading distance).
- Have a sphere requirement in the range -1.00 and -5.00D (-5.25D refractive)
- Have refractive astigmatism between 0.75D and 2.50D in both eyes.
- Achieve visual acuity of 20/30 or better in each eye with spherical distance correction.
- Have normal eyes with no evidence of abnormality or disease. For the purposes of this study a normal eye is defined as one having:
Exclusion Criteria
- Requires concurrent ocular medication.
- Clinically significant (Grade 3 or 4) corneal stromal haze, corneal vascularisation, tarsal abnormalities, bulbar hyperemia, limbal hyperemia, or any other abnormality of the cornea that would contraindicate contact lens wear.
- Corneal staining Grade 3 in more than one region.
- Has had refractive surgery. Has had eye injury/surgery within 8 weeks immediately prior to enrolment for this study.
- Abnormal lacrimal secretions.
- Pre-existing ocular irritation that would preclude contact lens fitting.
- Keratoconus or other corneal irregularity.
- Polymethyl methacrylate (PMMA) or Rigid Gas Permeable (RGP) lens wear in the previous 8 weeks
- Extended lens wear in last 3 months.
- Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear.
- Diabetic.
- Infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease (e.g., HIV).
- Pregnancy, lactating or planning a pregnancy at the time of enrolment.
- Participation in any concurrent clinical trial or in last 60 days.